IP Library Granted Patent US 8,168,392
Granted Patent B2
US 8,168,392 · App. 12/420,702 · Granted May 1, 2012

Tetrahydrofolate synthetase gene

Assignee: Daiichi Sankyo Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,168,392
App. No.
12/420,702
Granted
May 1, 2012
Kind
B2
Abstract

By finding a novel tetrahydrofolate synthetase gene and a protein encoded by said gene, a method for identifying a compound which inhibits cell growth accelerating activity of said protein is provided, and a judging method, a preventing method and a treating method of colon cancer are provided. A DNA comprising a nucleotide sequence of from the 94th to 2934th positions of the nucleotide sequence of SEQ ID NO:1 of the SEQUENCE LISTING; a polynucleotide which specifically hybridizes with said DNA; a protein encoded by said DNA; a recombinant vector comprising said DNA; a transformant comprising said recombinant vector; an antibody for said protein; a method for producing said protein; a method for identifying a compound which inhibits cell growth accelerating activity possessed by said protein; a method for judging colon cancer, characterizing in that expressed amount of said DNA is measured; a kit for judging colon cancer; a preventive agent and/or therapeutic agent for colon cancer.

Claims (6)

1. A method for identifying a compound that inhibits the cell growth accelerating activity of a tetrahydrofolate synthetase protein, wherein said protein comprises residues 1-978 of SEQ ID NO: 2, or comprises residues 32-978 of SEQ ID NO: 2, wherein said method comprises the steps of comprising:

(i) contacting a cell expressing said protein with a test compound under conditions which permit interaction between said protein and said test compound;

(ii) culturing said cell and determining the growth rate of said cell during said culturing; and

(iii) determining that the test compound inhibits the cell growth accelerating activity of said protein when the growth rate of said cell in the presence of said test compound is reduced in comparison to the growth rate of the cell in the absence of said test compound.

2. The method according to claim 1 , wherein the growth rate of said cell is determined by

counting the number of grown cells after the culturing.

Assignments (1)
MERGER Recorded Mar 30, 2012
From: DAIICHI PHARMACEUTICAL CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 027963/0751 →
Priority Claims (1)
JP 2003-341245 · Sep 30, 2003 · national
Continuity (2)
Division 10573969
Related Publication 20090226936A1 · Sep 10, 2009